{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:47:58Z","timestamp":1794268078844,"version":"4.9.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T00:00:00Z","timestamp":1763337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"],"award-info":[{"award-number":["Ricerca Corrente grant of the IRCCS Research Program n.4 Tuberculosis and Nontuberculous Mycobacterial"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23847-6","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:05:32Z","timestamp":1763413532000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical outcomes and adverse events of nontuberculous mycobacterial lung disease treated at an Italian tertiary referral center"],"prefix":"10.1038","volume":"15","author":[{"given":"Serena Maria","family":"Carli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mencarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Angela Vittoria","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Musso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Cerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelisa","family":"Mastrobattista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Vittozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Nisii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Mazzarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Navarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"De Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Ianniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina","family":"Gualano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"23847_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02029","author":"JR Honda","year":"2018","unstructured":"Honda, J. R., Virdi, R. & Chan, E. D. Global Environmental Nontuberculous Mycobacteria and Their Contemporaneous Man-Made and Natural Niches. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2018.02029 (2018). Published 2018 Aug 309:2029."},{"issue":"160","key":"23847_CR2","doi-asserted-by":"publisher","first-page":"200299","DOI":"10.1183\/16000617.0299-2020","volume":"30","author":"CS Thornton","year":"2021","unstructured":"Thornton, C. S. et al. The respiratory Microbiome and nontuberculous mycobacteria: an emerging concern in human health. Eur. Respir Rev. 30 (160), 200299 (2021). PMID: 34039671; PMCID: PMC9488710.","journal-title":"Eur. Respir Rev."},{"key":"23847_CR3","doi-asserted-by":"publisher","first-page":"106164","DOI":"10.1016\/j.rmed.2020.106164","volume":"173","author":"JA Schildkraut","year":"2020","unstructured":"Schildkraut, J. A. et al. Epidemiology of nontuberculous mycobacterial pulmonary disease in Europe and Japan by Delphi Estimation. Respir. Med. 173, 106164. https:\/\/doi.org\/10.1016\/j.rmed.2020.106164 (2020).","journal-title":"Respir. Med."},{"issue":"2","key":"23847_CR4","doi-asserted-by":"publisher","first-page":"132","DOI":"10.4415\/ANN_23_02_06","volume":"59","author":"F Giannoni","year":"2023","unstructured":"Giannoni, F., Lanni, A., Iacobino, A., Fattorini, L., Italian Multicentre Study on Nontuberculous Mycobacteria (IMS-NTM). & members of the IMS-NTM laboratory network Epidemiology and drug susceptibility of nontuberculous mycobacteria (NTM) in Italy in 2016\u20132020. Annali dell\u2019Istituto Superiore Di sanit\u00e0. 59 (2), 132\u2013138. https:\/\/doi.org\/10.4415\/ANN_23_02_06 (2023).","journal-title":"Annali dell\u2019Istituto Superiore Di sanit\u00e0"},{"issue":"3","key":"23847_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3201\/eid2403.171301","volume":"24","author":"C Lin","year":"2018","unstructured":"Lin, C. et al. Increasing prevalence of nontuberculous mycobacteria in respiratory specimens from US-Affiliated Pacific Island Jurisdictions1. Emerg. Infect. Dis. 24 (3), 485\u2013491. https:\/\/doi.org\/10.3201\/eid2403.171301 (2018). PMID: 29460734; PMCID: PMC5823340.","journal-title":"Emerg. Infect. Dis."},{"issue":"4","key":"23847_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/cid\/ciaa1125","volume":"71","author":"CL Daley","year":"2020","unstructured":"Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am. 71 (4), 905\u2013913. https:\/\/doi.org\/10.1093\/cid\/ciaa1125 (2020).","journal-title":"Clin. Infect. Diseases: Official Publication Infect. Dis. Soc. Am."},{"key":"23847_CR7","doi-asserted-by":"publisher","unstructured":"Haworth, C. S. et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. ;72(Suppl 2):ii1-ii64. (2017). https:\/\/doi.org\/10.1136\/thoraxjnl-2017-210927. PMID: 29054853.","DOI":"10.1136\/thoraxjnl-2017-210927"},{"issue":"3","key":"23847_CR8","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s15010-024-02183-3","volume":"52","author":"A Calcagno","year":"2024","unstructured":"Calcagno, A. et al. Drugs for treating infections caused by non-tubercular mycobacteria: a narrative review from the study group on mycobacteria of the Italian society of infectious diseases and tropical medicine. Infection 52 (3), 737\u2013765. https:\/\/doi.org\/10.1007\/s15010-024-02183-3 (2024).","journal-title":"Infection"},{"issue":"Suppl 1","key":"23847_CR9","doi-asserted-by":"publisher","first-page":"i1","DOI":"10.1136\/thoraxjnl-2015-207360","volume":"71","author":"RA Floto","year":"2016","unstructured":"Floto, R. A. et al. US cystic fibrosis foundation and European cystic fibrosis society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis. Thorax 71 (Suppl 1), i1\u201322. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-207360 (2016). PMID: 26666259; PMCID: PMC4717371.","journal-title":"Thorax"},{"issue":"2","key":"23847_CR10","doi-asserted-by":"publisher","first-page":"e0007083","DOI":"10.1371\/journal.pntd.0007083","volume":"13","author":"SL Baldwin","year":"2019","unstructured":"Baldwin, S. L., Larsen, S. E., Ordway, D., Cassell, G. & Coler, R. N. The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases. PLoS Negl. Trop. Dis. 13 (2), e0007083. https:\/\/doi.org\/10.1371\/journal.pntd.0007083 (2019). PMID: 30763316; PMCID: PMC6375572.","journal-title":"PLoS Negl. Trop. Dis."},{"key":"23847_CR11","unstructured":"World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-resistant tuberculosis, WHO\/HTM\/TB\/2014.11. Geneva, World Health Organization. (2014). Available from: apps.who.int\/iris\/bitstream\/10665\/130918\/1\/9789241548809_eng.pd"},{"issue":"5","key":"23847_CR12","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.chest.2023.12.006","volume":"165","author":"JH Ku","year":"2024","unstructured":"Ku, J. H. et al. Tolerability outcomes of American thoracic society\/Infectious diseases society of America Guideline-Recommended multidrug antibiotic treatment for Mycobacterium avium complex pulmonary disease in US medicare beneficiaries with bronchiectasis. Chest 165 (5), 1058\u20131069 (2024).","journal-title":"Chest"},{"key":"23847_CR13","doi-asserted-by":"crossref","unstructured":"van Ingen, J., Aksamit, T., Andrejak, C., B\u00f6ttger, E. C., Cambau, E., Daley, C. L.,Griffith, D. E., Guglielmetti, L., Holland, S. M., Huitt, G. A., Koh, W. J., Lange,C., Leitman, P., Marras, T. K., Morimoto, K., Olivier, K. N., Santin, M., Stout, J.E., Thomson, R., Tortoli, E., \u2026 for NTM-NET (2018). Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement.The European respiratory journal, 51(3), 1800170. https:\/\/doi.org\/10.1183\/13993003.00170-2018.","DOI":"10.1183\/13993003.00170-2018"},{"key":"23847_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/pathogens13040344)","volume":"13","author":"BK Mohanty","year":"2024","unstructured":"Mohanty, B. K., Eagan, T. M. L., Aarli, B. B., Skutlaberg, D. H. & Mustafa, T. Trends in Non-Tuberculous mycobacterial lung disease and treatment outcomes in a Low-Tuberculosis prevalence setting: A retrospective analysis. Pathogens 13, 344. https:\/\/doi.org\/10.3390\/pathogens13040344) (2024).","journal-title":"Pathogens"},{"issue":"1","key":"23847_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1186\/s12879-021-06825-x","volume":"21","author":"N Veziris","year":"2021","unstructured":"Veziris, N. et al. Non-tuberculous mycobacterial pulmonary diseases in france: an 8 years nationwide study. BMC Infect. Dis. 21 (1), 1165. https:\/\/doi.org\/10.1186\/s12879-021-06825-x (2021). PMID: 34789152; PMCID: PMC8600813.","journal-title":"BMC Infect. Dis."},{"key":"23847_CR16","doi-asserted-by":"publisher","first-page":"105899","DOI":"10.1016\/j.rmed.2020.105899","volume":"164","author":"S Aliberti","year":"2020","unstructured":"Aliberti, S. et al. Real-life evaluation of clinical outcomes in patients undergoing treatment for non-tuberculous mycobacteria lung disease: A ten-year cohort study. Respir Med. 164, 105899. https:\/\/doi.org\/10.1016\/j.rmed.2020.105899 (2020). Epub 2020 Feb 14. PMID: 32094101.","journal-title":"Respir Med."},{"issue":"5","key":"23847_CR17","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1164\/rccm.201908-1669OC","volume":"201","author":"KL Winthrop","year":"2020","unstructured":"Winthrop, K. L. et al. Treatment outcomes with macrolide-containing regimens for Mycobacterium avium complex lung disease. Am. J. Respir. Crit Care Med. 201 (5), 556\u2013563. https:\/\/doi.org\/10.1164\/rccm.201908-1669OC (2020).","journal-title":"Am. J. Respir. Crit Care Med."},{"issue":"3","key":"23847_CR18","doi-asserted-by":"publisher","first-page":"1602080","DOI":"10.1183\/13993003.02080-2016","volume":"49","author":"CL Daley","year":"2017","unstructured":"Daley, C. L. et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline. Eur. Respir. J. 49 (3), 1602080. https:\/\/doi.org\/10.1183\/13993003.02080-2016 (2017).","journal-title":"Eur. Respir. J."},{"issue":"2","key":"23847_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1378\/chest.11-1557","volume":"142","author":"WJ Koh","year":"2012","unstructured":"Koh, W. J. et al. Clinical significance of nontuberculous mycobacteria isolates in Korea. Chest 142 (2), 404\u2013411. https:\/\/doi.org\/10.1378\/chest.11-1557 (2012).","journal-title":"Chest"},{"issue":"6","key":"23847_CR20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.3201\/eid2206.151086","volume":"22","author":"5","year":"2016","unstructured":"5 et al. Epidemiology of pulmonary nontuberculous mycobacterial disease, Japan. Emerg. Infect. Dis. 22 (6), 1116\u20131117. https:\/\/doi.org\/10.3201\/eid2206.151086 (2016).","journal-title":"Emerg. Infect. Dis."},{"issue":"6","key":"23847_CR21","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1164\/rccm.201604-0681OC","volume":"195","author":"6","year":"2017","unstructured":"6 et al. Mycobacterium abscessus lung disease: analysis of clinical course and treatment outcomes. Am. J. Respir. Crit Care Med. 195 (6), 783\u2013790. https:\/\/doi.org\/10.1164\/rccm.201604-0681OC (2017).","journal-title":"Am. J. Respir. Crit Care Med."},{"key":"23847_CR22","doi-asserted-by":"publisher","unstructured":"Makek, M. J. et al. Nationwide evaluation of treatment outcomes and survival of patients with non-tuberculous mycobacterial pulmonary disease. Int J Tuberc Lung Dis. ;28(10):482\u2013487. (2024). https:\/\/doi.org\/10.5588\/ijtld.24.0068. PMID: 39334546.","DOI":"10.5588\/ijtld.24.0068"},{"key":"23847_CR23","doi-asserted-by":"publisher","first-page":"1394220","DOI":"10.3389\/fmicb.2024.1394220","volume":"15","author":"LE Conyers","year":"2024","unstructured":"Conyers, L. E. & Saunders, B. M. Treatment for non-tuberculous mycobacteria: challenges and prospects. Front. Microbiol. 15, 1394220. https:\/\/doi.org\/10.3389\/fmicb.2024.1394220 (2024). PMID: 38887711; PMCID: PMC11180805.","journal-title":"Front. Microbiol."},{"key":"23847_CR24","doi-asserted-by":"publisher","unstructured":"Nguyen, M. H. et al. Nontuberculous Mycobacterial Pulmonary Disease: Patients, Principles, and Prospects. Clin Infect Dis. ;79(4): e27-e47. (2024). https:\/\/doi.org\/10.1093\/cid\/ciae421. PMID: 39405483.","DOI":"10.1093\/cid\/ciae421"},{"issue":"1","key":"23847_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12931-024-02752-y","volume":"25","author":"M Marmor","year":"2024","unstructured":"Marmor, M., Sharifi, H., Jacobs, S., Fazeli, K. & Ruoss, S. Variables associated with antibiotic treatment tolerance in patients with Mycobacterium avium complex pulmonary disease. Respir Res. 25 (1), 123. https:\/\/doi.org\/10.1186\/s12931-024-02752-y (2024). Published 2024 Mar 11.","journal-title":"Respir Res."},{"key":"23847_CR26","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/cid\/ciaa252","volume":"72","author":"G Abate","year":"2021","unstructured":"Abate, G. et al. Variability in the management of adults with pulmonary nontuberculous mycobacterial disease. Clin. Infect. Dis. 72, 1127\u20131137 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"23847_CR27","first-page":"1271","volume":"25","author":"MA Campitelli","year":"2019","unstructured":"Campitelli, M. A. et al. Prescribing patterns for treatment of Mycobacterium avium complex and M. xenopi pulmonary disease in Ontario, Canada, 2001\u20132013. Emerg. Infect. Dis. 25, 1271\u20131280 (2019).","journal-title":"Emerg. Infect. Dis."},{"issue":"7","key":"23847_CR28","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/cid\/cix517","volume":"65","author":"N Kwak","year":"2017","unstructured":"Kwak, N. et al. Treatment outcomes of Mycobacterium avium complex lung disease: A systematic review and Meta-analysis. Clin. Infect. Dis. 65 (7), 1077\u20131084. https:\/\/doi.org\/10.1093\/cid\/cix517 (2017).","journal-title":"Clin. Infect. Dis."},{"issue":"163","key":"23847_CR29","doi-asserted-by":"publisher","first-page":"210212","DOI":"10.1183\/16000617.0212-2021","volume":"31","author":"K Kumar","year":"2022","unstructured":"Kumar, K., Daley, C. L., Griffith, D. E. & Loebinger, M. R. Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments. Eur. Respir Rev. 31 (163), 210212 (2022). PMID: 35140106; PMCID: PMC9488909.","journal-title":"Eur. Respir Rev."},{"issue":"12","key":"23847_CR30","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.5588\/ijtld.18.0171","volume":"22","author":"Y Kamii","year":"2018","unstructured":"Kamii, Y. et al. Adverse reactions associated with long-term drug administration in Mycobacterium avium complex lung disease. Int. J. Tuberc Lung Dis. 22 (12), 1505\u20131510. https:\/\/doi.org\/10.5588\/ijtld.18.0171 (2018).","journal-title":"Int. J. Tuberc Lung Dis."},{"issue":"1","key":"23847_CR31","doi-asserted-by":"publisher","first-page":"e256","DOI":"10.1093\/cid\/ciaa1361","volume":"73","author":"J van Ingen","year":"2021","unstructured":"van Ingen, J. et al. Management of drug toxicity in Mycobacterium avium complex pulmonary disease: an expert panel survey. Clin. Infect. Dis. 73 (1), e256\u2013e259. https:\/\/doi.org\/10.1093\/cid\/ciaa1361 (2021). PMID: 32910814; PMCID: PMC8491833.","journal-title":"Clin. Infect. Dis."},{"key":"23847_CR32","doi-asserted-by":"crossref","unstructured":"Ku, J. H. et al. Tolerability Outcomes of American Thoracic Society\/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Chest ;165(5):1058\u20131069. doi: 10.1016\/j.chest.2023.12.006. (2024). Epub 2023 Dec 10. PMID: 38086472; PMCID: PMC11214905.","DOI":"10.1016\/j.chest.2023.12.006"},{"key":"23847_CR33","doi-asserted-by":"crossref","first-page":"106089","DOI":"10.1016\/j.rmed.2020.106089","volume":"171","author":"HJ Kim","year":"2020","unstructured":"Kim, H. J. et al. Treatment outcomes of patients with Mycobacterium avium complex lung disease who discontinue treatment against medical advice. Respir Med. 171, 106089 (2020).","journal-title":"Respir Med."},{"key":"23847_CR34","doi-asserted-by":"publisher","unstructured":"Saukkonen, J. J. et al. ATS (American Thoracic Society) Hepatotoxicity of Antituberculosis Therapy Subcommittee. An official ATS statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med. ;174(8):935\u2009\u2013\u200952. (2006). https:\/\/doi.org\/10.1164\/rccm.200510-1666ST. PMID: 17021358.","DOI":"10.1164\/rccm.200510-1666ST"},{"key":"23847_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1164\/rccm.200407-863OC","volume":"172","author":"DE Griffith","year":"2005","unstructured":"Griffith, D. E. et al. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am. J. Respir Crit. Care Med. 172, 250\u2013253 (2005).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"9","key":"23847_CR36","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.3346\/jkms.2020.35.e59","volume":"35","author":"YS Kwon","year":"2020","unstructured":"Kwon, Y. S. et al. Treatment outcomes after discontinuation of ethambutol due to adverse events in Mycobacterium avium complex lung disease. J. Korean Med. Sci. 35 (9), e59. https:\/\/doi.org\/10.3346\/jkms.2020.35.e59 (2020). PMID: 32141249; PMCID: PMC7061143.","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"23847_CR37","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1164\/rccm.200407-863OC","volume":"172","author":"DE Griffith","year":"2005","unstructured":"Griffith, D. E. et al. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am. J. Respir Crit. Care Med. 172 (2), 250\u2013253. https:\/\/doi.org\/10.1164\/rccm.200407-863OC (2005).","journal-title":"Am. J. Respir Crit. Care Med."},{"issue":"7","key":"23847_CR38","doi-asserted-by":"publisher","first-page":"961","DOI":"10.5588\/ijtld.11.0574","volume":"16","author":"MW Carroll","year":"2012","unstructured":"Carroll, M. W. et al. Frequency of adverse reactions to first- and second-line anti-tuberculosis chemotherapy in a Korean cohort. Int. J. Tuberc Lung Dis. 16 (7), 961\u2013966. https:\/\/doi.org\/10.5588\/ijtld.11.0574 (2012).","journal-title":"Int. J. Tuberc Lung Dis."},{"key":"23847_CR39","doi-asserted-by":"crossref","unstructured":"Yoon, H. Y. et al. Clinical significance of QT-prolonging drug use in patients with MDR-TB or NTM disease. Int J Tuberc Lung Dis. ;21(9):996\u20131001. 10.5588\/ijtld.17.0174. PMID: 28826448,,& (2017). Pulmonary disease by non-tuberculous mycobacteria - clinical management, unmet needs and future perspectives. Expert review of respiratory medicine, 11(12), 977\u2013989. https:\/\/doi.org\/10.1080\/17476348.2017.1386563 (2017).","DOI":"10.5588\/ijtld.17.0174"},{"issue":"1","key":"23847_CR40","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12890-022-02063-2","volume":"22","author":"JY Kim","year":"2022","unstructured":"Kim, J. Y., Kim, N. Y., Jung, H. W., Yim, J. J. & Kwak, N. Old age is associated with worse treatment outcome and frequent adverse drug reaction in Mycobacterium avium complex pulmonary disease. BMC Pulm Med. 22 (1), 269. https:\/\/doi.org\/10.1186\/s12890-022-02063-2 (2022). PMID: 35836160; PMCID: PMC9284708.","journal-title":"BMC Pulm Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23847-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23847-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:05:41Z","timestamp":1763413541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23847-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23847"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23847-6","relation":{"references":[{"id-type":"doi","id":"10.3389\/fmicb.2018.02029","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of the National Institute for Infectious Diseases, \u201cL. Spallanzani\u201d IRCCS, with decision n.12 (17 February 2015). All enrolled patients provided written informed consent to the utilization of their anonymized clinical data. All research was performed in accordance with relevant guidelines\/regulations. Informed consent was obtained from all participants and\/or their legal guardians. Research has been performed in accordance with the the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board statement"}},{"value":"Informed consent was obtained from all subjects involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"40133"}}